New gel shows promise for eczema sufferers in Mid-Stage trial
NCT ID NCT06024499
First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests a gel called HY209 in 210 adults with mild to moderate atopic dermatitis (eczema). The gel is applied to the skin to see if it reduces redness, itching, and rash. Half the participants get the real gel, half get a placebo, and neither they nor the doctors know which is which. The main goal is to measure improvement in eczema severity over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cahaba Dermatology Skin Health Center
Birmingham, Alabama, 35244, United States
-
Continental Clinical Solutions, LLC
Towson, Maryland, 21204, United States
-
Gachon University Gil Medical Center
Seoul, South Korea
-
L.A. Universal Research Center, Inc.
Los Angeles, California, 90057, United States
-
RAOOF MD Dermatology
Encino, California, 16133, United States
-
Revival Research Institute, LLC
Southfield, Michigan, 19505, United States
-
Sadick Dermatology
New York, New York, 10075, United States
-
Seoul National University Bundang Hospital
Seoul, South Korea
-
Seoul National University Hospital
Seoul, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
Zenith Research Inc.
Los Angeles, California, 90212, United States
Conditions
Explore the condition pages connected to this study.